NBIX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neurocrine Biosciences Inc

Watchlist Manager

Watchlist

Price: 175.805 USD -1.81%

Market Cap: $17.7B

	Neurocrine Biosciences Inc NASDAQ:NBIX	US
	Alpha HPA Ltd F:3AU	AU
	Medipal Holdings Corp OTC:MEPDF	JP
	Next Biometrics Group ASA OSE:NEXT	NO
	OFS Capital Corp NASDAQ:OFS	US
S	Semtech Corp F:SM2	US
A	Angi Inc F:2UH	US
N	Nokia Oyj DUS:NOA3	FI
8	888 Holdings PLC F:C8V	GI
C	Costco Wholesale Corp XBER:CTO	US
	HashiCorp Inc F:YR8	US
	Informatica Inc NYSE:INFA	US
	AUO Corp F:AU7	TW
	Arcosa Inc NYSE:ACA	US
E	Electromagnetic Geoservices ASA F:E2M	NO

Profitability Summary

Neurocrine Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Gross Margin is Increasing

98% > 98%

Healthy Operating Margin

26%

Sustainable 3Y Average Operating Margin

22%

Operating Margin is Increasing

18% > 26%

Healthy Net Margin

22%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

11% > 22%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

23%

Free Cash Flow Margin is Increasing

17% > 27%

Positive ROE

23%

Positive 3Y Average ROE

Positive 3Y Average ROIC

22%

ROIC is Increasing

19% > 20%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.